You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

CLINICAL TRIALS PROFILE FOR ANDRODERM


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for ANDRODERM

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00965341 ↗ Testosterone Replacement for Fatigue in Male Hypogonadic Advanced Cancer Patients Completed M.D. Anderson Cancer Center Phase 3 2009-09-01 The goal of this clinical research study is to learn if and how testosterone replacement therapy may affect fatigue in males with advanced cancer and low testosterone levels.
NCT00975650 ↗ Efficacy and Tolerability of an Intra-Nasal Testosterone Product Completed Acerus Pharmaceuticals Corporation Phase 2 2009-08-01 This clinical trial is being performed to compare the pharmacokinetic profile of testosterone after repeated intra-nasal administration of products of different strengths in subjects with hypogonadism.
NCT00975650 ↗ Efficacy and Tolerability of an Intra-Nasal Testosterone Product Completed Trimel Biopharma SRL Phase 2 2009-08-01 This clinical trial is being performed to compare the pharmacokinetic profile of testosterone after repeated intra-nasal administration of products of different strengths in subjects with hypogonadism.
NCT01187485 ↗ A Randomized Study of Testosterone Replacement in Patients With Low Risk Hormone Refractory Prostate Cancer Completed University of Chicago Phase 1 2004-06-01 The purpose of this study is to see how safe Androderm® (the study drug) is at three different doses in subjects with early hormone refractory prostate cancer. In addition, information about hormonal levels and the effects of testosterone on quality of life including sexual functioning and muscle strength will be collected.
NCT04320745 ↗ A Study to Evaluate Androderm's Effect on Blood Pressure in Adult Hypogonodal Male Participants. Completed Allergan Phase 4 2020-05-19 This study will evaluate the effect of a once daily Androderm dose on Blood Pressure (BP) in adult hypogonadal men as measured by 24-hour ABPM
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for ANDRODERM

Condition Name

Condition Name for ANDRODERM
Intervention Trials
Hypogonadism 2
Advanced Cancer 1
Prostate Cancer 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for ANDRODERM
Intervention Trials
Hypogonadism 2
Prostatic Neoplasms 1
Neoplasms 1
Fatigue 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for ANDRODERM

Trials by Country

Trials by Country for ANDRODERM
Location Trials
United States 26
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for ANDRODERM
Location Trials
Texas 3
Florida 2
California 2
Arizona 2
Louisiana 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for ANDRODERM

Clinical Trial Phase

Clinical Trial Phase for ANDRODERM
Clinical Trial Phase Trials
Phase 4 1
Phase 3 1
Phase 2 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for ANDRODERM
Clinical Trial Phase Trials
Completed 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ANDRODERM

Sponsor Name

Sponsor Name for ANDRODERM
Sponsor Trials
M.D. Anderson Cancer Center 1
Acerus Pharmaceuticals Corporation 1
Trimel Biopharma SRL 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for ANDRODERM
Sponsor Trials
Industry 3
Other 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.